Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Weekly Finger-Prick test may keep elderly patients safer on blood thinners

NCT ID NCT05561244

Disease control Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether checking blood clotting levels every week with a small finger-prick device is better than the usual monthly lab test for elderly nursing home residents on blood thinners. The goal was to see which method keeps patients in the safe therapeutic range longer, reducing risks of clots or bleeding. The trial was terminated early, so results are limited.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
CoaguChek INRange® device for capillary INR monitoring
What this could lead to
If successful, this could show that weekly at-home finger-prick tests help elderly patients on blood thinners stay in a safer range, reducing clot or bleed risks.
What could go wrong
The trial was terminated early with only 45 participants, so results are limited. The approach may not work for all patients or settings, and finger-prick tests can be less accurate than lab draws.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

45 people

The number who actually took part.

Started

Nov 2022

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: The population corresponds to nursing homes patients treated with Vitamin K Antagonists for more than six months, because INRc cannot be used while anticoagulation treatment is being introduced. * The patient or his/her trusted-person/legal representative/tutor signed the consent form * The patient is an adult and lives in a nursing home * The patient has been on treatment with Vitamin K Antagonists for more than six months * The patient's target INR range is 2,5 \[2-3\] or 3 \[2,5-3,5\] * The patient is affiliated to a health insurance program Exclusion Criteria: * The patient is participating in a Type 1 interventional study involving human beings (Jardé law). * The patient is in an exclusion period determined by another study * The patient is under safeguard of justice. * It is not possible to give the patient (or his/her trusted-person/legal representative/tutor) informed information. * The patient has a short life expectancy (\< 1 month) * The Karnofky index is ≤ 20%

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Atrial fibrillation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

atrial fibrillation thrombotic disease venous thromboembolism Venous Thrombosis stroke disorder prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Atrial fibrillation Deep vein thrombosis Stroke

Contacts and locations

Locations

  • Centre Bellevue-CHU Montpellier

    Montpellier, 34090, France

  • EHPAD " Coté Canal "

    Aigues-Mortes, GARD, 30220, France

  • EHPAD "Docteur Henry Granet"

    Aramon, GARD, 30390, France

  • EHPAD "Jacques Saurin"

    Moussac, GARD, 30190, France

  • EHPAD "Jean Lasserre"

    Euzet, GARD, 30360, France

  • EHPAD "Korian Mas de Lauze"

    Nîmes, 30900, France

  • EHPAD "La BELLE Viste"

    Saint-Gély-du-Fesc, Hérault, 34980, France

  • EHPAD "Les 5 sens Garons"

    Garons, GARD, 30128, France

  • EHPAD "Les Capitelles"

    Bernis, GARD, 30620, France

  • EHPAD "Les Dominicaines"

    Ganges, Hérault, 34190, France

  • EHPAD "Les Jardins de l'Escalette"

    Uzès, GARD, 30700, France

  • EHPAD "Les Jasses"

    Fons, GARD, 30730, France

  • EHPAD "Les Monts d'Aurelle"

    Montpellier, Hérault, 34097, France

  • EHPAD "Les oliviers"

    Montfrin, GARD, 30490, France

  • EHPAD "Ma Maison"

    Nîmes, GARD, 30000, France

  • EHPAD "Résidence les Magnans"

    Saint-Martin-de-Valgalgues, GARD, 30520, France

  • EHPAD "Samdo Rochebelle"

    Alès, GARD, 30100, France

  • EHPAD "Sophia la Capitelle"

    Meynes, GARD, 30840, France

  • EHPAD "Villa Rediciano"

    Redessan, GARD, 30129, France

  • EHPAD Korian "Les Meunières"

    Lunel, HERAULT, 34400, France

  • EHPAD La Murelle

    Laurens, 34480, France

  • EHPAD La Pinède

    Vergèze, 30310, France

  • EHPAD Léon Bourgeois

    Vilallonga dels Monts, 66740, France

  • EHPAD Malbosc

    Montpellier, HERAULT, 34090, France

  • EHPAD ORPEA "Château Notre Dame"

    Parignargues, GARD, 30730, France

  • EHPAD Résidence "Les Caprésianes"

    Cabrières, GARD, 30210, France

  • EHPAD Résidence "l'Accueil"

    Vauvert, GARD, 30600, France

  • EHPAD Saint-Vincent de Paul

    Le Grau-du-Roi, GARD, 30240, France

  • EHPAD Serre-Cavalier Sites 1 and 2

    Nîmes, GARD, 30000, France

  • EHPAD du centre hospitalier de Langogne

    Langogne, LOZERE, 48300, France

  • Maison de Retraite Protestante

    Montpellier, Hérault, 34090, France

  • Nîmes University Hospital, Place du Pr. Debré

    Nîmes, Gard, 30029, France

  • SCM Médicale St Bauzille de Putois

    Saint-Bauzille-de-Putois, HERAULT, 34190, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.